Related Experiment Video
Updated: Jan 10, 2026
09:12
Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
Published on: March 28, 2025
602
GPR55: Metabolic Help or Hindrance?
Christopher M Henstridge1, Andrew J Brown2, Maria Waldhoer3
1Centre for Cognitive and Neural Systems, University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ, UK.
Trends in Endocrinology and Metabolism: TEM
|May 25, 2016
Summary
The G protein-coupled receptor (GPCR) GPR55 shows potential for treating metabolic disorders like obesity and diabetes. Further research is needed to clarify its role in these conditions.
Area of Science:
- Endocrinology
- Metabolic Research
- Pharmacology
Background:
- The lysophospholipid-sensitive receptor GPR55, a G protein-coupled receptor (GPCR), has emerged as a potential therapeutic target.
- Its precise physiological role, particularly in metabolic regulation, remains incompletely understood.
- Conflicting data exists regarding GPR55's involvement in metabolic homeostasis.
Purpose of the Study:
- To review and synthesize the current evidence on GPR55's function in metabolic disorders.
- To evaluate the potential of targeting GPR55 for therapeutic interventions.
- To highlight GPR55 as a novel target for obesity and diabetes treatment.
Main Methods:
- Literature review of studies investigating GPR55.
- Analysis of conflicting data on GPR55's physiological roles.
- Discussion of GPR55's implications in metabolic disease models.
Main Results:
- Evidence suggests GPR55 activation influences metabolic pathways.
- Inconsistent findings complicate a definitive understanding of GPR55's effects.
- GPR55 modulation may offer a novel therapeutic strategy.
Conclusions:
- GPR55 represents a promising, albeit complex, target for metabolic disease therapies.
- Clarifying GPR55's precise mechanisms is crucial for drug development.
- Targeting GPR55 warrants further investigation for obesity and diabetes treatment.
